Patient monitoring solutions developer Sensifree launched a joint development program with Cleveland Clinic to develop a device for non-invasive monitoring of blood pressure.
The joint development, which received a grant from the BIRD Foundation, aims to help Sensifree develop the next generation of a device for non-invasive monitoring of blood pressure and other hemodynamic parameters. The product is intended for professional use and is expected to improve quality of care, patient safety, and medical outcome of hospitalized patients.
“We are excited and proud to win this vote of confidence by the BIRD foundation,” says Eran Agmon, CEO and co-founder of Sensifree. “Cleveland Clinic’s experience in this subject matter and high academic standards are a true asset for moving the science forward.”
Cleveland Clinic will test and clinically validate the device.
“A continuous non-invasive blood pressure monitor would be valuable for clinicians. Blood pressure monitoring is a focus for the department of Outcome Research because hypotension is common and potentially serious,” says Daniel Sessler, MD, director of the department of Outcome Research at the Cleveland Clinic.
